Citadel Advisors »

Exagen shares owned by Citadel Advisors

Quarter-by-quarter ownership of Exagen (XGN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Exagen

Tip: Access up to 7 years of quarterly data

All positions including Exagen held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exagen by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4M 130k 10.99
2025-03-31 $94k 26k 3.59
2024-12-31 $122k 30k 4.10
2024-09-30 $86k 28k 3.09
2024-06-30 $51k 28k 1.82
2024-03-31 $21k 13k 1.59
2023-12-31 $42k 21k 1.99
2023-03-31 $29k 12k 2.43
2022-06-30 $913k 160k 5.72
2022-03-31 $874k 109k 8.03